Metraipolis › archive › dc_562cd0d513c4

Engineering exosomes for targeted neurodegenerative therapy: innovations in biogenesis, drug loading, and clinical translation — Europe PMC PMID:41328354

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41328354
DOI
10.7150/thno.117143
License (as archived)
solo-consultazione
Archived
2026-11-07T05:14:25.104Z
SHA-256 of the archived text
54e9496d72421d5820501dc349fe55349440d0ab450f4c800653e23104fd7022
Stable URL of this page
https://metraipolis.com/documento/dc_562cd0d513c4

How to cite

Engineering exosomes for targeted neurodegenerative therapy: innovations in biogenesis, drug loading, and clinical translation — Europe PMC PMID:41328354 — Europe PMC (en), https://europepmc.org/article/MED/41328354 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_562cd0d513c4 (Metraipolis archive dc_562cd0d513c4, sha256 54e9496d72421d5820501dc349fe55349440d0ab450f4c800653e23104fd7022)
BibTeX
@misc{dc562cd0d513c4,
  title = {Engineering exosomes for targeted neurodegenerative therapy: innovations in biogenesis, drug loading, and clinical translation — Europe PMC PMID:41328354},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41328354},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_562cd0d513c4; sha256 54e9496d72421d5820501dc349fe55349440d0ab450f4c800653e23104fd7022},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41328354. Agents can read the archived copy with the MCP tool read_document.